Quick Takeaways
- Commodore Capital LP filed SCHEDULE 13G for Solid Biosciences Inc. Common Stock $0.001 par value per share (SLDB).
- Disclosed ownership: 7.6%.
- Date of event: 18 Feb 2025.
Commodore Capital LP - 18 Feb 2025 SCHEDULE 13G Report for Solid Biosciences Inc. Common Stock $0.001 par value per share (SLDB)
- Filing Manager
- Commodore Capital LP
- Reporting Manager
- COMMODORE CAPITAL LP
- Symbol
- SLDB
- Shares outstanding
- 76,644,737 shares
- Disclosed Ownership
- 5,825,000 shares
- Ownership
- 7.6%
- Form type
- SCHEDULE 13G
- Filing time
- 25 Feb 2025, 16:05:13 UTC
- Date of event
- 18 Feb 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Commodore Capital LP disclosed 7.6% ownership in Solid Biosciences Inc. Common Stock $0.001 par value per share (SLDB) on 18 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 25 Feb 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| COMMODORE CAPITAL LP | 7.6% | 5,825,000 | 0 | 5,825,000 | /s/ Michael Kramarz | Michael Kramarz, Managing Partner | |
| Commodore Capital Master LP | 7.6% | 5,825,000 | 0 | 5,825,000 | /s/ Michael Kramarz | Michael Kramarz, Authorized Signatory |